Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2006.09.0100 on April 9 2007

Journal of Clinical Oncology, Vol 25, No 15 (May 20), 2007: pp. 1993-1999
© 2007 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kristinsson, S. Y.
Right arrow Articles by Björkholm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kristinsson, S. Y.
Right arrow Articles by Björkholm, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003

Sigurdur Yngvi Kristinsson, Ola Landgren, Paul W. Dickman, Åsa Rangert Derolf, Magnus Björkholm

From the Division of Hematology, Department of Medicine, and Department of Medical Epidemiology and Biostatistics, Karolinska University Hospital and Institutet, Stockholm, Sweden; and Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

Address reprint requests to Magnus Björkholm, MD, Division of Hematology, Department of Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden; e-mail: magnus.bjorkholm{at}karolinska.se

Purpose To define patterns of survival among all multiple myeloma (MM) patients diagnosed in Sweden during a 30-year period.

Patients and Methods A total of 14,381 MM patients (7,643 males; 6,738 females) were diagnosed in Sweden from 1973 to 2003 (median age, 69.9 years; range 19 to 101 years). Patients were categorized into six age categories and four calendar periods (1973 to 1979, 1980 to 1986, 1987 to 1993, and 1994 to 2003). We computed relative survival ratios (RSRs) as measures of patient survival.

Results One-year survival improved (P < .001) over time in all age groups and RSRs were 0.73, 0.78, 0.80, and 0.82 for the four calendar periods; however, improvement in 5-year (P < .001) and 10-year (P < .001) RSR was restricted to patients younger than 70 years and younger than 60 years, respectively. For the first time, in analyses restricted to MM patients diagnosed at age younger than 60 years, we found a 29% (P < .001) reduced 10-year mortality in the last calendar period (1994 to 2003) compared with the preceding calendar period (1987 to 1993). Females with MM had a 3% (P = .024) lower excess mortality than males.

Conclusion One-year MM survival has increased for all age groups during the last decades; 5-year and 10-year MM survival has increased in younger patients (younger than 60 to 70 years). High-dose melphalan with subsequent autologous stem-cell transplantation, thalidomide, and a continuous improvement in supportive care measures are probably the most important factors contributing to this finding. New effective agents with a more favorable toxicity profile are needed to improve survival further, particularly in the elderly.

published online ahead of print at www.jco.org on April 9, 2007.

Supported by grants from the Swedish Cancer Society, Stockholm County Council, and the Karolinska Institutet Foundations.

Presented in part at the 46th Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego, CA; and the 9th Annual Congress of the European Hematology Association, June 10-13, 2004, Geneva, Switzerland.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
haematolHome page
S. Y. Kristinsson, P. W. Dickman, W. H. Wilson, N. Caporaso, M. Bjorkholm, and O. Landgren
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden
Haematologica, September 1, 2009; 94(9): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Hulin, T. Facon, P. Rodon, B. Pegourie, L. Benboubker, C. Doyen, M. Dib, G. Guillerm, B. Salles, J.-P. Eschard, et al.
Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
J. Clin. Oncol., August 1, 2009; 27(22): 3664 - 3670.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Varettoni, A. Corso, G. Pica, S. Mangiacavalli, C. Pascutto, and M. Lazzarino
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
Ann. Onc., July 24, 2009; (2009) mdp329v1.
[Abstract] [Full Text] [PDF]


Home page
Qual Saf Health CareHome page
M Staples, M Elwood, J St John, F Howes, and K Pedersen
Perceived impact on clinical practice and logistical issues in clinical management surveys of cancer: Australian experience
Qual. Saf. Health Care, June 1, 2009; 18(3): 195 - 198.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Y. Kristinsson, A. R. Derolf, G. Edgren, P. W. Dickman, and M. Bjorkholm
Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden
J. Clin. Oncol., April 20, 2009; 27(12): 2073 - 2080.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
J. Blade and L. Rosinol
Changing paradigms in the treatment of multiple myeloma
Haematologica, February 1, 2009; 94(2): 163 - 166.
[Full Text] [PDF]


Home page
haematolHome page
H. Brenner, A. Gondos, and D. Pulte
Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010
Haematologica, February 1, 2009; 94(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Lazarus, G. L. Phillips, R. H. Herzig, D. D. Hurd, S. N. Wolff, and G. P. Herzig
High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later
J. Clin. Oncol., May 10, 2008; 26(14): 2240 - 2243.
[Full Text] [PDF]


Home page
BloodHome page
S. K. Kumar, S. V. Rajkumar, A. Dispenzieri, M. Q. Lacy, S. R. Hayman, F. K. Buadi, S. R. Zeldenrust, D. Dingli, S. J. Russell, J. A. Lust, et al.
Improved survival in multiple myeloma and the impact of novel therapies
Blood, March 1, 2008; 111(5): 2516 - 2520.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online